Study suggests repurposing anti-depressant medication to target medulloblastoma

(Cincinnati Children's Hospital Medical Center) An international research team reports in Nature Medicine a novel molecular pathway that causes an aggressive form of medulloblastoma, and suggests repurposing an anti-depressant medication to target the new pathway may help combat one of the most common brain cancers in children. The scientists say their laboratory findings in mouse models of the disease could lead to a more targeted and effective molecular therapy that would also reduce the harmf...